20 Mar 2019 | 5:40 PM
 

Natco Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524816 | NSE Symbol: NATCOPHARM
597.96
0.25
(0.05 %)
20 Mar 2019 | 04:01 PM
Change company
  • Open (Rs)
    600.00
  • Prev. close (Rs.)
    597.71
  • High (Rs.)
    604.00
  • Low (Rs.)
    594.35
  • 52W H (Rs.)
    841.70
  • 52W L (Rs.)
    558.00
  • Volume
    8140
  • MCap (Rs in Cr.)
    11,000.01
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
37.74
Operating Margin (%)
42.49
Gross Profit Margin (%)
39.46
Net Profit Margin (%)
31.86
Total Debt/Equity
0.06
Dividend payout Ratio (Net Profit)
26.09
Earning Retention Ratio
73.87

News

12 Feb 2019 - 17:11:00-The company reported standalone net profit of Rs 162...
31 Jan 2019 - 14:49:00-Natco Pharma Thursday said it has submitted an abbreviated new drug application (ANDA) with the US h...
25 Jan 2019 - 14:41:00-Natco Pharma Friday announced to set up greenfield agrichemical manufacturing facilities with an inv...
05 Nov 2018 - 16:43:00-Natco Pharma Monday reported over two-fold increase in consolidated profit after tax at Rs 181...

Announcements

15-Mar-2019
Natco Pharma - Buyback
15-Mar-2019
Natco Pharma - Corporate Action-Intimation of Buy back
06-Mar-2019
Natco Pharma - Press Release
06-Mar-2019
Natco Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
18-Feb-2019
Natco Pharma - Investor Presentation

Religare Research

28 Feb 2019 | 10:15 AM
• Agri markets kept trading with high volatility with no strong directions, even as prices seem to f...
04 Feb 2019 | 11:57 AM
Agri Fundamental & Technical Report
21 Jan 2019 | 07:35 PM
Weekly report
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,00,000 90.05 29.80 0.00
4,00,000 90.05 143.97 0.01
4,00,000 90.05 152.84 0.01
4,00,000 90.05 51.32 0.02
1,60,000 35.89 74.49 -0.35

Shareholding Pattern

       
Promotors48.42%
Mutual Funds/UTI5.13%
FI/Banks0.96%
Insurance0.96%
FII23.82%
Government0.00%
Others3.93%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
7,362.00(0.20)
3280
 Sanofi India Ltd.
5,595.00(-0.49)
3325
 Pfizer Ltd.
3,207.15(0.82)
3370
 Dr. Reddy`s Laboratories Ltd.
2,749.70(1.67)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Natco Pharma Ltd.24.40-107.00-200.05
NIFTY(S&P CNX)880.10612.35242.15
BSE SENSEX2,888.312,039.671,096.08
BSE 5001,261.61583.50-81.40

Corporate Details

Key Personal
D Linga Rao
Director & President (Tech. Affairs)
P S R K Prasad
Director & Exe. VP (Corp. Engg. Services)
Rajeev Nannapaneni
Vice Chairman & CEO
Key Address
Registered Office
NATCO House Road # 2 Banjara Hills,Hyderabad,Telangana

Tel:040-23547532, Fax:040-23548243

investors@natcopharma.co.in
http://www.natcopharma.co.in
Registrar Office
Venture Capital & Corporate Investments Pvt. Ltd.
Add. :No. 12-10-167 Bharat Nagar